IFNG and breast cancer: Using both 2D and 3D models of BC cells, we unraveled the mechanisms by which treatment with IFN-γ + TNF-α can enhance NK cell function and potentially overcome the immune evasion mechanisms employed by tumors, particularly in aggressive BC subtypes such as TNBC.